// App-Quantinova.ai

1104-078 : A RANDOMIZED COMPARISON OF SECOND-GENERATION ZOTAROLIMUS-ELUTING RESOLUTE STENTS VERSUS EVEROLIMUS-ELUTING XIENCE V STENTS IN REAL-WORLD PATIENTS: 4-YEAR LONG-TERM CLINICAL OUTCOMES OF LISA-ERX TRIAL

Researchers

Presenter

  • Yisik Kim

Principal Investigators

  • Jei Keon Chae

  • Ji Young Yoon

  • Soo Kyeong Song

  • Lae Young Jung

  • Sun Hwa Lee

  • Sang Rok Lee

  • Kyoung Seok Lee

  • Jae Ki Ko

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved